1. Home
  2. FCFS vs GKOS Comparison

FCFS vs GKOS Comparison

Compare FCFS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FirstCash Holdings Inc.

FCFS

FirstCash Holdings Inc.

HOLD

Current Price

$164.76

Market Cap

7.2B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$113.29

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCFS
GKOS
Founded
1988
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.4B
IPO Year
1991
2015

Fundamental Metrics

Financial Performance
Metric
FCFS
GKOS
Price
$164.76
$113.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
14
Target Price
$168.75
$127.71
AVG Volume (30 Days)
253.5K
641.9K
Earning Date
01-29-2026
02-19-2026
Dividend Yield
1.02%
N/A
EPS Growth
27.90
N/A
EPS
6.92
N/A
Revenue
$3,486,435,000.00
$469,820,000.00
Revenue This Year
$8.28
$31.15
Revenue Next Year
$10.44
$24.15
P/E Ratio
$23.87
N/A
Revenue Growth
3.86
30.38
52 Week Low
$104.99
$73.16
52 Week High
$168.36
$163.71

Technical Indicators

Market Signals
Indicator
FCFS
GKOS
Relative Strength Index (RSI) 59.58 58.14
Support Level $154.23 $109.07
Resistance Level $168.36 $115.00
Average True Range (ATR) 3.66 2.76
MACD 0.33 -0.95
Stochastic Oscillator 79.50 44.01

Price Performance

Historical Comparison
FCFS
GKOS

About FCFS FirstCash Holdings Inc.

FirstCash Holdings Inc operates pawn stores in the United States and Latin America. Its primary business involves making small loans secured by personal property. The the company has three reportable segments: U.S. pawn; Latin America pawn; and Retail POS payment solutions (AFF). It derives majority revenue from U.S. Pawn segment. These pawn loans give the borrower the option of either repaying the loans with interest or forfeiting the property without further penalty. Geographically operates in USA, Mexico, Latin America, with maximum revenue from USA.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: